RINDBeRG Trial Overview Study Design: An open-label, randomized Phase III trial conducted in Japan from February 2017 to August 2022, involving 402 patients with advanced or recurrent gastric or gastroesophageal…
Interactive Cancer Care Network (ICCN) strives to provide Community Oncologists with medical education regarding the most up to date drug approvals and treatment landscape changes. Providing insights from national key opinion leaders allows for the opportunity to ask questions relevant to your clinical practice. At this time we offer virtual programs tailoring to the busy schedules of medical providers. We look forward to having you join the ICCN community.